143 related articles for article (PubMed ID: 17111200)
1. Osteoprotegerin is not associated with angiographic coronary calcification.
Gogo PB; Schneider DJ; Terrien EF; Sobel BE; Dauerman HL
J Thromb Thrombolysis; 2006 Dec; 22(3):177-83. PubMed ID: 17111200
[TBL] [Abstract][Full Text] [Related]
2. Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention.
Erkol A; Pala S; Kırma C; Oduncu V; Dündar C; Izgi A; Tigen K; Gibson CM
Am J Cardiol; 2011 Mar; 107(6):857-62. PubMed ID: 21247537
[TBL] [Abstract][Full Text] [Related]
3. Values of osteoprotegerin in aortic valve tissue in patients with significant aortic stenosis depend on the existence of concomitant coronary artery disease.
Fojt R; Pirk J; Kamenický P; Karpíšek M; Straka Z; Malý M; Moťovská Z
Cardiovasc Pathol; 2016; 25(3):181-184. PubMed ID: 26874038
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin levels change during STEMI and reflect cardiac function.
Lindberg S; Jensen JS; Hoffmann S; Iversen AZ; Pedersen SH; Mogelvang R; Galatius S; Flyvbjerg A; Bjerre M
Can J Cardiol; 2014 Dec; 30(12):1523-8. PubMed ID: 25475457
[TBL] [Abstract][Full Text] [Related]
5. Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.
Gogo PB; Schneider DJ; Terrien EF; Watkins MW; Sobel BE; Dauerman HL
Am J Cardiol; 2005 Aug; 96(4):538-42. PubMed ID: 16098308
[TBL] [Abstract][Full Text] [Related]
6. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.
Asanuma Y; Chung CP; Oeser A; Solus JF; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
Atherosclerosis; 2007 Dec; 195(2):e135-41. PubMed ID: 17570371
[TBL] [Abstract][Full Text] [Related]
7. Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein.
Rhee EJ; Lee WY; Kim SY; Kim BJ; Sung KC; Kim BS; Kang JH; Oh KW; Oh ES; Baek KH; Kang MI; Woo HY; Park HS; Kim SW; Lee MH; Park JR
Clin Sci (Lond); 2005 Mar; 108(3):237-43. PubMed ID: 15569000
[TBL] [Abstract][Full Text] [Related]
8. The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans.
Rhee EJ; Oh KW; Jung CH; Lee WY; Oh ES; Yun EJ; Baek KH; Kang MI; Kim SW
Clin Endocrinol (Oxf); 2006 Jun; 64(6):689-97. PubMed ID: 16712673
[TBL] [Abstract][Full Text] [Related]
9. Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI.
Saia F; Komukai K; Capodanno D; Sirbu V; Musumeci G; Boccuzzi G; Tarantini G; Fineschi M; Tumminello G; Bernelli C; Niccoli G; Coccato M; Bordoni B; Bezerra H; Biondi-Zoccai G; Virmani R; Guagliumi G;
JACC Cardiovasc Imaging; 2015 May; 8(5):566-575. PubMed ID: 25890582
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
Gibson CM; Karmpaliotis D; Kosmidou I; Murphy SA; Kirtane AJ; Budiu D; Ray KK; Herrmann HC; Lakkis N; Kovach R; French W; Blankenship J; Lui HH; Palabrica T; Jennings LK; Cohen DJ; Morrow DA;
Am J Cardiol; 2006 May; 97(10):1473-7. PubMed ID: 16679086
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammation after drug-eluting stent placement.
Gogo PB; Schneider DJ; Watkins MW; Terrien EF; Sobel BE; Dauerman HL
J Thromb Thrombolysis; 2005 Apr; 19(2):87-92. PubMed ID: 16052297
[TBL] [Abstract][Full Text] [Related]
12. Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification.
Pérez de Ciriza C; Moreno M; Restituto P; Bastarrika G; Simón I; Colina I; Varo N
Clin Biochem; 2014 Dec; 47(18):272-8. PubMed ID: 25218813
[TBL] [Abstract][Full Text] [Related]
13. Computed tomographic angiography-verified plaque characteristics and slow-flow phenomenon during percutaneous coronary intervention.
Kodama T; Kondo T; Oida A; Fujimoto S; Narula J
JACC Cardiovasc Interv; 2012 Jun; 5(6):636-43. PubMed ID: 22721658
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction.
Ko YG; Jung JH; Park S; Choi E; Joung B; Hwang KC; Ha JW; Choi D; Jang Y; Chung N; Shim WH; Cho SY
Int J Cardiol; 2006 Sep; 112(1):66-71. PubMed ID: 16309761
[TBL] [Abstract][Full Text] [Related]
15. Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.
Hong YJ; Jeong MH; Choi YH; Ko JS; Lee MG; Kang WY; Lee SE; Kim SH; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
J Cardiol; 2009 Aug; 54(1):36-44. PubMed ID: 19632518
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction.
Çanga A; Durakoğlugil ME; Erdoğan T; Kirbaş A; Yilmaz A; Çiçek Y; Ergül E; Çetin M; Kocaman SA
J Cardiol; 2012 Nov; 60(5):355-60. PubMed ID: 22727437
[TBL] [Abstract][Full Text] [Related]
17. Role of C-reactive protein in determining microvascular function in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
Sezer M; Akdeniz C; Aslanger E; Kaplan A; Yilmaz A; Guz G; Umman B; Bugra Z; Umman S
Am J Cardiol; 2013 Jun; 111(12):1734-8. PubMed ID: 23558042
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].
Shiota J; Izumi N; Kasahara H; Tagawa H; Chiba T; Nihei H
Nihon Jinzo Gakkai Shi; 2010; 52(8):1022-8. PubMed ID: 21254698
[TBL] [Abstract][Full Text] [Related]
19. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
[TBL] [Abstract][Full Text] [Related]
20. Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients.
Kurnatowska I; Grzelak P; Kaczmarska M; Stefańczyk L; Nowicki M
Nephron Clin Pract; 2011; 117(4):c297-304. PubMed ID: 20861651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
